Literature DB >> 3014111

Alpha-1 and alpha-2 adrenoceptor: response coupling in canine saphenous and femoral veins.

N A Flavahan, P M Vanhoutte.   

Abstract

The aim of the present study was to analyze alpha-1 and alpha-2 adrenoceptor response coupling in isolated canine blood vessels. Rings of saphenous and femoral veins and of femoral arteries were suspended for isometric tension recording in modified Krebs-Ringer bicarbonate solution, gassed with 95% O2-5% CO2 and maintained at 37 degrees C. Dissociation constants for the alpha-1 adrenergic agonists, phenylephrine and cirazoline, and the alpha-2 adrenergic agonist, UK 14,304, were determined by analysis of concentration-effect curves to the agonists under control conditions and after partial inactivation of alpha adrenoceptors by phenoxybenzamine. The dissociation constant of phenylephrine for alpha-1 adrenoceptors in saphenous veins was approximately 10-fold higher than that obtained for the agonist in femoral arteries or femoral veins. Similarly the dissociation constant for cirazoline in the saphenous vein was higher than that obtained in other alpha-1 adrenergic systems. Dissociation constants were used to determine alpha adrenoceptor occupancy-response relationships. The alpha-1 adrenergic responses evoked by high intrinsic-efficacy agonists (cirazoline and phenylephrine) were associated with a very large receptor-reserve in the saphenous vein, but no, or only a limited receptor-reserve in the femoral vein. The dissociation constant for UK 14,304 in saphenous veins was significantly lower than that obtained for alpha-2 adrenergic stimulation by norepinephrine. There was no alpha-2 adrenoceptor reserve in the saphenous vein for these putative high intrinsic-efficacy agonists. The differences in receptor-reserve between alpha-1 adrenoceptors in canine saphenous and femoral veins and between alpha-1 and alpha-2 adrenoceptors in saphenous veins may help to explain the differential modulation of adrenergic responses in these blood vessels.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3014111

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  10 in total

Review 1.  Regulation of vascular reactivity in scleroderma: new insights into Raynaud's phenomenon.

Authors:  Nicholas A Flavahan
Journal:  Rheum Dis Clin North Am       Date:  2008-02       Impact factor: 2.670

2.  Identification of alpha 1L-adrenoceptor in mice and its abolition by alpha 1A-adrenoceptor gene knockout.

Authors:  I Muramatsu; S Morishima; F Suzuki; H Yoshiki; A S M Anisuzzaman; T Tanaka; M C Rodrigo; B E Myagmar; P C Simpson
Journal:  Br J Pharmacol       Date:  2008-09-22       Impact factor: 8.739

3.  Evidence that the population of postjunctional-adrenoceptors mediating contraction of smooth muscle in the rabbit isolated ear vein is predominantly alpha 2.

Authors:  C J Daly; J C McGrath; V G Wilson
Journal:  Br J Pharmacol       Date:  1988-08       Impact factor: 8.739

Review 4.  Intracellular α(2C)-adrenoceptors: storage depot, stunted development or signaling domain?

Authors:  Maqsood A Chotani; Nicholas A Flavahan
Journal:  Biochim Biophys Acta       Date:  2011-05-14

5.  Alpha-adrenoceptor subtypes in dog saphenous vein that mediate contraction and inositol phosphate production.

Authors:  P E Hicks; M Barras; G Herman; P Mauduit; J M Armstrong; B Rossignol
Journal:  Br J Pharmacol       Date:  1991-01       Impact factor: 8.739

6.  H1-receptor reserves in guinea-pig left atria, trachea and pig coronary artery as identified by phenoxybenzamine.

Authors:  E Rappen-Cremer; U Borchard; D Hafner; F Berger
Journal:  Agents Actions       Date:  1989-11

7.  Native profiles of alpha(1A)-adrenoceptor phenotypes in rabbit prostate.

Authors:  T-H Su; S Morishima; F Suzuki; H Yoshiki; A S M Anisuzzaman; T Tanaka; J-T Cheng; I Muramatsu
Journal:  Br J Pharmacol       Date:  2008-08-11       Impact factor: 8.739

8.  Acute dilation to alpha(2)-adrenoceptor antagonists uncovers dual constriction and dilation mediated by arterial alpha(2)-adrenoceptors.

Authors:  P A Crassous; S Flavahan; N A Flavahan
Journal:  Br J Pharmacol       Date:  2009-09-28       Impact factor: 8.739

9.  The alpha1A-adrenoceptor gene is required for the alpha1L-adrenoceptor-mediated response in isolated preparations of the mouse prostate.

Authors:  Kt Gray; Jl Short; S Ventura
Journal:  Br J Pharmacol       Date:  2008-06-16       Impact factor: 8.739

10.  Expression of distinct alpha 1-adrenoceptor phenotypes in the iris of pigmented and albino rabbits.

Authors:  I Muramatsu; F Suzuki; A Nishimune; A S M Anisuzzaman; H Yoshiki; T-H Su; C-K Chang; S Morishima
Journal:  Br J Pharmacol       Date:  2009-05-12       Impact factor: 8.739

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.